Stay updated with the latest pharmaceutical-industry news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on pharmaceutical-industry topics.
New Delhi, Oct 16 (PTI) Shares of pharmaceutical company Rubicon Research Ltd on Thursday listed with a premium of nearly 28 per cent against the issue price of Rs 485. The stock started trading at Rs 620.10, up 27.85 per cent, from the issue price on the BSE. At the NSE, the stock made its debut at Rs 620, registering a jump of 27.83 per cent. The company's market valuation stood at Rs 9,917.97 crore. The initial public offer of Rubicon Research garnered 103.90-times subscription on the clo ...Read More >
Mumbai (Maharashtra) [India], October 16 (ANI): The Indian share market opened on a positive note on Thursday, supported by optimism over a possible India-US trade deal expected in November. However, experts cautioned that the markets are currently in an overbought zone and may witness some correction in the near term. The Nifty 50 index opened at 25,394.90, gaining 71.35 points or 0.28 per cent, while the BSE Sensex started the day at 82,794.79, up by 189.36 points or 0.23 per cent. Market s ...Read More >
Amid growing demand for stricter compliance with safety and quality control norms for medical products, the Centre is framing a law to strengthen the legal framework for drug quality testing and market surveillance, along with regulation of medical devices and cosmetics. One of the major reasons behind the drafting of the law is the repeated complaints and concerns flagged by health regulators across the globe, including the WHO, over serious quality lapses by Indian drug manufacturers. The dr ...Read More >
Bengaluru: Even as brickbats kept streaming in from ministers for a second straight day, Biocon chief Kiran Mazumdar-Shaw Wednesday found an ally in Bangalore Rural MP Dr CN Manjunath, who supported the entrepreneur and urged Karnataka govt to take her post on Bengaluru infrastructure as constructive suggestion and act accordingly to make Bengaluru globally competitive. He called the criticism "not justifiable".On her part, Kiran Shaw clarified her post was not political and it was simply a dema ...Read More >
Madhya Pradesh: A district court has denied bail to paediatrician Dr Praveen Soni, arrested in the Coldrif cough syrup deaths case, after police informed the court that he confessed to receiving a 10% commission from the pharmaceutical company for prescribing the medicine. The syrup has been linked to multiple child deaths and cases of kidney failure. Commission Kickbacks And Fatal Outcomes During police interrogation, Dr Soni admitted to taking a 10% cut from the company for promoting Coldrif ...Read More >
New Delhi, Oct 9 (PTI) Drug firm Lupin on Thursday announced the launch of a strategic partnership programme aimed at expanding the reach of a long-acting injectable platform developed by its subsidiary, Nanomi BV. The platform, PrecisionSphere demonstrates efficacy and safety in drug delivery and is ready for commercial use, following the recent US Food and Drug Administration (USFDA) approval for the first product developed with this platform. The company's partnership programme is designed ...Read More >
Bhopal/Nagpur, Oct 9 (PTI) With 22 children from Madhya Pradesh dying due to consumption of Coldrif cough syrup, Chief Minister Mohan Yadav on Thursday warned of taking "strict action" and said his government will not spare anyone playing with the lives of children. Twenty-two children, mostly from Chhindwara in MP, died due to suspected kidney failure following the consumption of the cough syrup manufactured by a Tamil Nadu-based pharmaceutical company. The Madhya Pradesh police arrested Rang ...Read More >
MUMBAI, India and NAPLES, Fla., Oct. 9, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of a strategic partnership program aimed at expanding the reach of PrecisionSphere™ - the long-acting injectable (LAI) platform developed by its subsidiary, Nanomi B.V. (Nanomi). PrecisionSphere™ demonstrates efficacy and safety in drug delivery and is ready for commercial use, following the recent Unit ...Read More >
CHENNAI: A week after reporting poor manufacturing and laboratory practices in Sresan Pharmaceuticals, the company that manufactured the lethal cough syrup that killed more than 20 children in Madhya Pradesh, the state health department suspended two former senior drug inspectors on charges of negligence for failing to inspect the unit, Health Minister Ma Subramanian said here on Thursday.Senior drug inspectors, Deepa Joseph and K Karthikeyan, who served in the Kancheepuram zone, were placed und ...Read More >
Tests revealed the presence of diethylene glycol -- a poisonous substance used in brake fluid and antifreeze -- known to cause acute kidney failure, especially in children. Follow TNM's channel for news updates and story links. Tamil Nadu Health Minister Ma Subramanian on Wednesday, October 8, said that the state government will initiate criminal action against the Kancheepuram-based pharmaceutical company that produced Coldrif, the contaminated cough syrup which caused the deaths of several c ...Read More >
The World Health Organization is seeking details from India regarding a cough syrup linked to child deaths. Several Indian states have banned the 'Coldrif' syrup. Lab reports confirmed it contained a toxic industrial solvent. A criminal case has been registered against the manufacturer, Sresan Pharma. The doctor who prescribed the syrup has been arrested. The World Health Organization on Wednesday sought clarification from Indian authorities on whether a cough syrup linked to deaths of children ...Read More >
Representatives of Indian Medical Association (IMA), Madhya Pradesh Branch and doctors held a protest in Chhindwara district on Tuesday, demanding the release of a government doctor, Praveen Soni, who was recently sent to jail in relation to the death of children due to alleged consumption of cough syrup in the district. Dr Soni is a government paediatrician at Civil Hospital, Parasia in Chhindwara, who was recently suspended and later faced legal action, resulting in being sent on 14-days judi ...Read More >
After the death of at least 20 children in Madhya Pradesh due to the consumption of contaminated cough syrup, the Central Drugs Standard Control Organisation (CDSCO) on Wednesday issued a strict advisory for drug controllers of all states and Union Territories and instructed them to ensure every batch of raw material and finished formulation is properly tested before use or sale. The advisory, dated October 7, 2025, was sent by Dr Rajeev Singh Raghuvanshi, Drug Controller General of India (DCGI ...Read More >
The affected children are from MP's Chhindwara, Rajasthan, and Maharashtra, while states like Kerala and Telangana have issued public alerts banning the use of Coldrif syrup. The Central Drugs Standard Control Organisation (CDSCO) has recommended the cancellation of the manufacturing licence of the Tamil Nadu-based pharmaceutical company that produced the cough syrup 'Coldrif', after tests confirmed the presence of diethylene glycol (DEG), a toxic substance, in the formulation, according to gov ...Read More >
NEW DELHI, Oct 8 (Reuters) - Some Indian pharmaceutical firms failed to follow rules that every batch of medicinal ingredients is tested, the country's drug regulator said on Wednesday, opens new tab, after deaths in the past month of 17 children linked to toxic cough syrups. An advisory by the drugs controller general of India, Rajeev Raghuvanshi, said the regulator carried out checks at some factories and found serious lapses. In the advisory dated October 7 and posted on a government website ...Read More >
Bhopal, Oct 8 (PTI) Madhya Pradesh minister Narendra Shivaji Patel on Wednesday blamed the Tamil Nadu government for the death of 20 children from his state due to kidney infections caused by the consumption of an alleged contaminated cough syrup. He said the southern state showed "grave negligence" as it was its responsibility to inspect the medicines going out of the state. Patel also asserted that while the MP government randomly inspects medicines coming into the state, it was "by chance" ...Read More >
"We arrived here last night. We are conducting the probe. He (owner of the drug company) had left the premises three days ago. We are collecting details based on the CCTV footage (available at the registered office)," an official part of the SIT told PTI. An official of Ashok Nagar Police station here said the SIT is being assisted by the Tamil Nadu police locally and they are conducting inspection at the registered premises of the drug manufacturing company. "They conducted the inspection at ...Read More >
Bhopal/Chandigarh, Oct 7 (PTI) The Punjab Government has banned the sale and use of Coldrif cough syrup, the move coming in the wake of deaths of 14 children in Madhya Pradesh, linked to consumption of the medicine. Punjab has become the latest state after Goa, Haryana, Himachal Pradesh, Karnataka, Maharashtra, Rajasthan, Uttar Pradesh, and Uttarakhand to impose curbs on the distribution of the syrup. A PIL was filed in the Supreme Court seeking inquiry and systemic reform in drug safety mecha ...Read More >
(Reuters) -Eli Lilly will invest more than $1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, as it seeks to tap into skilled workforce to bolster its global manufacturing expansion. The collaborations aim to increase the availability of Lilly's key drugs, including those for obesity, diabetes, Alzheimer's, cancer and autoimmune conditions, the company said. "We are making significant investments to increase manufactu ...Read More >
The Union health ministry addressed cough syrup quality. A meeting reviewed drug norm compliance. This followed child deaths linked to syrups in Chhindwara and Rajasthan. States received advice on cough syrup use for children. One cough syrup, Coldrif, contained DEG beyond limits. Action occurred against the manufacturer. Inspections began across 19 units. Officials urged adherence to manufacturing practices. Amid concerns over the quality of cough syrups, the Union health ministry on Sunday un ...Read More >
The Indian Pharmaceutical Alliance (IPA) has appointed Sharvil Patel of Zydus Lifesciences as its new President, with Glenn Saldanha of Glenmark as Vice President. This leadership transition occurs as the industry navigates GST reforms and strengthens its global position in specialty medicines. The new team aims to drive innovation, patient access, and quality healthcare solutions. The Indian Pharmaceutical Alliance (IPA) has appointed Sharvil Patel, Managing Director of Zydus Lifesciences as i ...Read More >
NCDC collected water and entomological drug samples from Madhya Pradesh and Rajasthan after multiple children died of kidney failure, allegedly linked to contaminated cough syrup. These samples will be tested for infectious diseases, while state drug authorities await results from drug sample tests. Six children died in MP and one in Rajasthan, prompting a ban on 19 syrup batches. The government's nodal agency for disease surveillance, NCDC, has collected water and entomological drug samples fr ...Read More >
New Delhi, Oct 1 (PTI) India will not only attract USD 100 billion committed investments from the four-nation EFTA bloc under a trade agreement, but also look at an additional USD 150 billion, Commerce and Industry Minister Piyush Goyal said on Wednesday. He said that huge opportunities are there for companies from these four countries to invest in India. Under the India-EFTA trade and economic partnership agreement (TEPA), New Delhi has received a commitment of USD 100 billion FDI from EFTA o ...Read More >
Jaipur: A tragic incident has come to light from Rajasthan. Dexamethasone syrup manufactured by a pharmaceutical company for the state government, has reportedly caused the deaths of two children and left at least ten others ill over the past two weeks. In a shocking turn, a doctor who consumed the syrup to prove it was safe lost consciousness and was found in his car eight hours later. The incident came to light when a five-year-old boy died hours after being given a dose of the syrup on Mond ...Read More >
India's trade body has started a probe. It is investigating Chinese aluminium foil imports. The Directorate General of Trade Remedies will check for government subsidies. This investigation covers a period from April 2024 to March 2025. Domestic companies claim injury from these subsidised imports. This is not the first such trade action against Chinese foil. The Directorate General of Trade Remedies (DGTR) has initiated a countervailing duty (CVD) investigation into Chinese aluminium foil (80 ...Read More >
NEW DELHI: Following the tragic deaths of six children in Madhya Pradesh's Chhindwara district from acute kidney failure, the Union health ministry has launched a comprehensive, multi-agency investigation. A team from the National Centre for Disease Control (NCDC) has been deployed to the region, officials familiar with the matter said. Health officials strongly suspect a contaminated cough syrup is responsible for the fatalities. Preliminary reports suggest the over-the-counter medicine may ha ...Read More >
Jaipur: The pharmaceutical company at the centre of a recent cough syrup scare in Rajasthan allegedly has a history of regulatory compliance issues, which have resurfaced following the death of a five-year-old boy in Sikar district after consuming one of their medicines.The company, Kaysons Pharma, was previously debarred by the state health department for two years due to non-compliance of drug supply contracts. Department officials said the decision stemmed from the company's failure to delive ...Read More >
Mumbai, Sep 30 (PTI) The rupee fell 4 paise to an all-time low of 88.79 (provisional) against the US dollar on Tuesday, pressured by sustained foreign capital outflows amid global trade uncertainties. However, a steep fall in global crude oil prices, along with a weaker greenback, prevented a sharp decline in the local unit, according to forex traders. The markets are also awaiting the Reserve Bank of India's (RBI's) Monetary Policy Committee decision, which will be announced on Wednesday. At ...Read More >
New Delhi, Sep 30 (PTI) Pharmaceutical company Virupaksha Organics has filed preliminary papers with capital markets regulator Sebi to raise Rs 740 crore through an initial public offering (IPO). The proposed IPO of the Hyderabad-based company is entirely a fresh issue of equity shares, according to the draft red herring prospectus (DRHP) filed on Monday. The company may consider raising Rs 148 crore in a pre-IPO placement round. If such placement is undertaken, then the issue size will be red ...Read More >
Mumbai, Sep 29 (PTI) Rupee consolidated in a narrow range and settled for the day lower by 3 paise at 88.75 against the US dollar on Monday, on persistent foreign capital outflows and rise in risk-off sentiments. Forex traders said rupee is hovering near its all-time low level as investors remained concerned over global trade uncertainties and impact of US visa fee hike on India's IT services exports. Moreover, the Reserve Bank of India (RBI) policy meeting outcome on October 1, is expected to ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.